hypertension medications

Hypertension medications
These medications are marketed under several brand names: we list the pharmacological name.
Diuretics (water pills)
Thiazide and related diuretics: hydrochlorothiazide, chlorthalidone, indipamide, metolazone, bendroflumethazide.
Diuretics may cause low potassium: a potassium supplement may be used or the diuretic can be combined with a drug that prevents potassium loss.
Potassium sparing diuretics: amiloride, spironolactone, triamterene

ACE-I ACE inhibitors: benazepril, captopril, cilazapril, enalapril, enalaprilat, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril
ARB: angiotensin receptor blockers Valsartan Telmisartan Losartan Irbesartan Olmesartan
CCB Calcium Channel Blockers Amlodipine Felodipine Nicardipine Nifedipine Nimodipine Nisoldipine Nitrendipine Lacidipine Lercanidipine.
Beta Blockers Nadolol, propranolol, timolol, acebutolol, atenolol, bisoprolol, esmolol, metoprolol.*** see below***

***A study was done to compare beta blockers + older diuretic V. CCB and newer diuretic in high risk hypertensive patients to see if they had a better outlook in preveting new heart attacks, strokes or death from heart failure. These patients had hypertension and at least three other risk factors (cholesterol, obesity, diabetes etc.)

Patients were given either amlodipine and perindopril (indipamide) , or atenolol and bendroflumethiazide.

Fewer individuals on the amlodipine-based drugs had fatal and non-fatal strokes, cardiovascular events, or developed diabetes compared with with those taking the atenolol-based group of drugs.

nonfatal myocardial infarction and fatal CHD reduced by 13%
total coronary events 13%
total cardiovascular events and procedures 16%
fatal and non-fatal stroke 23%.
unstable angina 32%
peripheral artery disease 35%
kidney function impairment 15%.

These patients were high risk because of their multiple risk factors: the results may not be the same for uncomplicated hypertension.